Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 85% TCA for LSIL Treatment
NCT06525870Phase 2Enrolling by invitation
- Sponsor
- Ministry of Public Health
- Start
- Aug 2024
- Primary completion
- Sep 2025
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trichloroacetic acid in squamous intraepithelial lesion of the cervix (SIL), sponsored by Ministry of Public Health. Started Aug 2024; status: enrolling by invitation.
02
Drugs
trichloroacetic acid
03
Conditions
squamous intraepithelial lesion of the cervix (SIL)
Beyond the preview
Go deeper on NCT06525870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06525870.